Setting: Two tertiary care hospitals and 12 peripheral health institutions (PHIs) in Trivandrum, Kerala, India. Objective: To determine factors associated with the prevalence of diabetes mellitus (DM) among tuberculosis (TB) patients and examine differences in the proportion of new DM cases among TB patients diagnosed at tertiary care centres and PHIs. Design: A descriptive study: TB patients diagnosed during March-September 2012 were screened for known DM. Those with unknown DM status were tested for random blood glucose and fasting blood glucose (FBG); FBG ⩾ 126 mg/dl was diagnosed as new DM. Results: Of 920 TB patients, 689 (72%) were male and the mean (standard deviation) age was 47.6 (16.4) years. Of these, 298 (32.4%) were diabetic: 235 (26%) had previously known DM and 63 (7%) were newly diagnosed. During the screening at PHIs and tertiary care hospitals, respectively 30/183 (16.4%) and 33/737 (4.5%) were newly diagnosed with DM (OR 3.71; 95%CI 2.17-6.32). Overall, age >50 years and pulmonary tuberculosis were independently associated with a higher prevalence of diabetes. Conclusion: As nearly one in three TB patients had DM, we recommend that TB patients should be routinely screened for DM in Kerala. As the proportion of new DM was higher among TB patients diagnosed at PHIs, we would recommend that specific attention and investment be directed to PHIs.
I
ndia, the country with the highest number of tuberculosis (TB) cases in the world (an estimated 2.2 million cases in 2011), 1 also has a very high burden of diabetes mellitus (DM), with an estimated 63 million cases in 2012. 2 In India, 15% of pulmonary tuberculosis (PTB) cases have been estimated to be attributable to DM. 3 DM also affects TB treatment outcomes and may delay sputum conversion, increase case fatality rates during treatment, lead to increased failure rates in non-drug-resistant cases and also increase relapse rates of TB after successful completion of treatment. 4, 5 Given this scenario, it has been felt that active screening for DM in TB patients may allow identifi cation of previously undiagnosed DM and improve TB treatment outcomes through improved DM care.
Diabetes is common in Kerala, a state in South India with a population of 34.6 million, with an estimated community prevalence of 16-20%. 6, 7 The state treated 25 917 TB patients in 2012, including all types of TB. 8 Kerala is known to have a high prevalence of DM in TB patients, with a recent study reporting a prevalence of 44%. 9 As standardised procedures for DM screening among TB patients for use in hospitals and TB units (TUs)-a sub-district level tuberculosis programme management unit covering a population of 500 000, made up of varying numbers of peripheral health institutions (PHIs)-were not available in India, a monitoring tool linked to the TB registration and quarterly reporting system was developed and implemented, starting in multiple centres in India in 2012. The fi ndings of this pilot study 10 showed that the screening procedures worked well, and the overall prevalence of DM in over 8000 screened TB patients was 13%. Trivandrum, in Kerala, was one of the sites that implemented screening at both hospital and fi eld level in the TU, allowing for comparison of the yield from the different levels of screening.
This study aimed to determine factors associated with the diagnosis of DM during screening of TB patients under programme conditions. Specifi c objectives were to determine 1) the prevalence of DM, 2) the demographic and clinical factors associated with prevalence of DM, and 3) whether the yield of newly diagnosed DM was different in tertiary care facilities compared to that in PHIs.
METHODS

Study design
This descriptive study was part of a national level implementation project on bidirectional TB-DM screening performed within the routine health services in India in 2012. 10 
Study setting
The study was conducted in Trivandrum City in Kerala, a state in the south of India. In 2012, 1750 smearpositive TB patients were diagnosed and 2676 TB patients (including pulmonary smear-positive, pulmonary smear-negative and extra-pulmonary TB) were registered for treatment in Trivandrum district. 8 According to national guidelines, 11 TB patients are classifi ed as PTB based on sputum smear examination for acidfast bacilli (AFB) or, in those who are sputum smearnegative, by chest radiograph within 2 weeks of the negative result being obtained. Extra-pulmonary TB cases are diagnosed by the treating doctor based on a combination of radiology, histopathology, demonstration of AFB by smear or culture and/or clinical features. All TB patients are treated with a short-course,
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fully intermittent (thrice weekly), standardised treatment regimen containing rifampicin throughout, delivered under direct observation. The three centres that took part in the study in Trivandrum included two tertiary care hospitals and a TU consisting of 12 PHIs. The two hospitals were the Government Medical College Hospital, Trivandrum, and the Chest Disease Hospital, Pulayanarkotta. The Government Medical College Hospital is a 1916-bed, multi-specialty teaching hospital, with a daily outpatient load of 1800 and approximately 850 cases of TB diagnosed annually. The Chest Disease Hospital, Pulayanarkotta, which caters for patients with respiratory diseases, including TB, has 508 beds and a daily out-patient load of about 60; some 325 TB patients are diagnosed and treated there every year. As TB care in India is mainly domiciliary, TB patients are referred to peripheral centres to continue their treatment, and the hospitals provide in-patient care only for the management of complications or co-morbidities. The fi eldlevel programme management unit that participated in the study was the Trivandrum DTC (district TB centre) TU (covering a population of 0.5 million), which consists of 12 health care facilities, providing diagnosis of TB and directly observed treatment for TB patients. This unit registered 413 TB patients in 2012.
Trivandrum is the southernmost district of Kerala, with both a rural and an urban population. Patients are referred to the tertiary care hospitals from the PHIs or from private hospitals. Smaller PHIs are used by a predominantly rural population, whereas the tertiary care hospitals receive patients from both urban and rural areas. All of these hospitals provide free or subsidised care for patients. As a pulmonary care centre, the Chest Disease Hospital deals more with PTB, whereas the Government Medical College Hospital has various speciality departments providing care for extra-pulmonary TB patients.
Study participants
All TB patients aged ⩾15 years diagnosed consecutively at the two hospitals, or those registered for treatment at the Trivandrum DTC TU, between March and September 2012 made up the study population 
Data collection and analysis
The methods of screening, recording and reporting have been described in detail elsewhere. 10 Briefl y, all TB patients were asked whether they had DM, and those with unknown DM status underwent random blood glucose (RBG) testing. If RBG was ⩾110 mg/dl, the patient was screened for fasting blood glucose (FBG). If FBG was ⩾126 mg/dl, DM was diagnosed. Venous blood samples were collected for blood sugar level measurement at the participating centre. Data on age, sex, smoking status (current smoker was defi ned as a person who smoked in the last month), RBG and FBG values were collected in the TB-DM register, the study tool, by the fi eld-level worker of the Revised National TB Control Programme (RNTCP), and were cross-checked by the District TB Offi cer of Trivandrum, the Medical Offi cer of the Medical College RNTCP cell and the principal investigator. The main outcomes for analysis were the number and proportion (with 95% confi dence interval [CI]) of TB patients with a diagnosis of DM (previously known and newly diagnosed), stratifi ed by age, sex, place of diagnosis and type of TB. Bivariate analysis was conducted to examine whether those factors were associated with the prevalence of DM. Odds ratios (OR) with 95%CI were used to measure associations. Multivariate analysis using logistic regression was conducted to calculate the adjusted OR. Only those variables that were statistically signifi cant (P < 0.05) in bivariate analysis were considered for multivariate analysis. EpiData Version 3.5.3 (EpiData Association, Odense, Denmark) was used to analyse the data.
Ethics approval
The study was approved by the Institutional Ethics Committee of Government Medical College, Trivandrum. As this was a pilot project aiming to test the feasibility of DM screening among TB patients with a view to learning lessons for national scale-up approved by RNTCP authorities, the requirement for individual informed consent was waived by the Institutional Ethics Committee. All diagnosed DM patients were linked to DM care. Permission to use, report and publish the collected data in the pilot study was also obtained from 
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RESULTS
A total of 948 TB patients were screened in all three sites. Of these, 920 (97%) fi nished the entire screening process, completing all their required blood measurements. These 920 patients were included in the analysis. Of these, 670 (72%) were male and the mean (standard deviation) age was 47.8 (16.2) years. The median (interquartile range) age was 49 (37-59) years. The profi le of the patients screened and the overall prevalence of DM among TB patients, desegregated by age, sex, smoking status and type of TB and for each site, are shown in Table 1 . TB patients diagnosed at the Medical College Hospital had a higher proportion of extrapulmonary TB, females and those aged ⩽50 years. Of the 920 TB patients screened, 298 (32%) were diagnosed with DM. Of these, 63 (21%) were newly diagnosed DM cases, whereas 235 (79%) had previously known DM. The proportion of new DM was higher among TB patients diagnosed at PHIs compared to those at tertiary care hospitals. Factors associated with a higher prevalence of DM among the TB patients are shown in Table 2 . Age >50 years, male sex, PTB and current smoking were associated with higher prevalence of DM on bivariate analysis. In multivariate modelling, only age >50 years and PTB were found to be independently associated with DM.
Factors associated with the prevalence of new (previously undiagnosed) DM among the TB patients are shown in Table 3 . Diagnosis in a PHI, age >50 years and PTB were found to be independently associated with new DM after multivariate modelling.
DISCUSSION
We found a high prevalence of DM among TB patients treated in Trivandrum; it was signifi cantly higher among those aged >50 years and in those with PTB. The prevalence of DM among the TB patients was higher in Trivandrum than in the other sites that took part in the pilot study (personal communication, SS): the overall prevalence of diabetes in TB patients in the nationwide pilot was 13%, 10 whereas that in the Trivandrum centres was 32.4%.
More than three quarters of the TB patients with DM knew their DM status before the screening; however, this proportion was lower among TB patients screened at PHIs. Among the TB patients screened at peripheral TU level, more than half the cases of DM diagnosed were new cases. This probably indicates that patients reaching the major hospitals have multiple opportunities for screening before the diagnosis of TB, whereas patients diagnosed with TB at peripheral level are likely to miss a diagnosis of DM if they do not undergo active screening after TB diagnosis.
The high prevalence of DM among TB patients in Trivandrum could be explained by the high prevalence of DM in the general population in Kerala, which, as reported by previous studies among the adult population, is 16-20%, 6, 7 and is much higher than in other states in India. TB patients in Kerala are also older than in other Indian states, which could be another reason for the high prevalence of DM in TB patients. The prevalence of TB is lower in Kerala than in the rest of the country. 12, 13 Kerala also has a lower prevalence of human immunodefi ciency virus (HIV) infection in the general population compared to other states of South India: the prevalence of HIV in the general population of India is 0.31% compared to 0.19% in Kerala. 14 DM could therefore be one of the main factors driving the TB epidemic in Kerala, unlike other high TB burden countries. 15 A study looking at the prevalence of DM in TB patients in Kerala showed a high prevalence of DM, with 44% of TB patients having the disease. 9 However, this prevalence was determined by glycated haemoglobin (HbA1c) testing, which is not feasible in fi eld conditions. The use of the HbA1c measurement could also be the reason for the higher diagnosis of DM in TB patients. This study also showed that almost half the DM patients diagnosed on screening were unaware of their DM status at the time of screening, and they would have remained undiagnosed if the screening had not been undertaken. Factors associated with a diagnosis of DM in TB patients in that study were male sex and age >50 years.
The strengths of this study are that a large number of TB patients were consecutively screened in the study sites in Trivandrum and are thus representative. Trivandrum was the only one 
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of two cities where screening was performed at both tertiary care hospital and PHI level, allowing a comparison to be made between the two different sites of screening of the yield and proportion of new DM diagnosed in the same population. Also, the use of a screening tool developed at national level allows for a comparison of the proportion of DM diagnosed in Trivandrum to that in other states in India. Possible limitations of the study include the lack of information on other possible confounding factors, as the information collected was limited to that included in the screening tool. Only patients notifi ed to the RNCTP were included in the screening. There is a possibility that some patients, particularly those with extra-pulmonary TB being treated with individualised regimens outside the RNTCP, were not included in the study. This study has major policy implications. First, it demonstrates the feasibility of screening for DM in TB patients using a standard screening tool. Second, it reiterates the high prevalence of DM in TB patients in Kerala, highlighting once again the importance of DM as a risk factor for TB in Kerala. Third, it demonstrates that screening for DM in TB patients at fi eld level results in a higher proportion of previously undiagnosed DM patients being detected, which shows the importance of early screening of TB patients at fi eld level. The RNTCP can also support India's non-communicable disease programme by early diagnosis of DM in a group of patients who would otherwise be undiagnosed, linking them to care and with a consequent reduction in morbidity and mortality. All of this requires close coordination between the RNTCP and the National Non-Communicable Disease Control Programme.
This study reinforces the view that DM screening in TB patients should be part of the minimum standard of care offered to all TB patients in Kerala and that it needs to be a high priority area for implementation. The state of Kerala has since taken a policy decision to screen all of its TB patients for DM. The government of India subsequently also made this a policy for the rest of the country. In addition, steps have been taken to link the RNTCP and the National Non-Communicable Disease Control Programme at PHI level in Kerala, allowing for DM screening and improved care of TB patients diagnosed with DM.
CONCLUSION
This study confi rms the high prevalence of DM in TB patients in Kerala and that a signifi cant proportion of DM patients may not be aware of their status; screening for diabetes is thus an urgent requirement and a minimum standard of care for TB patients, particularly at fi eld level. . En general, una edad >50 años y la presencia de TB pulmonar fueron factores asociados de manera independiente con una mayor prevalencia de DM. Conclusión: Cerca de uno de cada tres pacientes TB presentaba DM; por esta razón se recomienda la detección sistemática de la DM en los pacientes con diagnóstico de TB en Kerala. La proporción de casos nuevos de DM fue mayor en los pacientes TB diagnosticados en los centros periféricos de atención sanitaria, por lo cual se preconiza prestar una mayor atención a este aspecto y realizar inversiones específicas en estos centros.
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